Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevation Oncology (ELEV)
NASDAQ:ELEV
Elevation Oncology (ELEV) Stock Forecast & Price Target
47 Followers
See the Price Targets and Ratings of:
See bloggers sentiment and opinion on ELEV
>ELEV Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ELEV Stock 12 Months Forecast
There Are No Analyst Ratings for ELEV In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
ELEV Financial Forecast
Detailed List of Analyst Forecasts
TD Cowen
―
Buy
―
Reiterated
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevation Oncology (NASDAQ: ELEV), Novartis AG (Six Swiss: CH:NOVN) and VBI Vaccines (NASDAQ: VBIV)
Wedbush
$6.00
Buy
791.53%
Upside
Reiterated
Elevation Oncology (ELEV) PT Raised to $6 at WedbushWedbush analyst Robert Driscoll raised the price target on Elevation Oncology (NASDAQ: ELEV) to $6.00 (from $4.00) while maintaining a Outperform rating.
Leerink Partners
$8.00
Buy
1088.71%
Upside
Upgraded
Elevation Oncology upgraded to Outperform from Market Perform at SVB SecuritiesElevation Oncology upgraded to Outperform from Market Perform at SVB Securities
Best Analysts Covering Elevation Oncology
Which Analyst Should I Follow If I Want to Buy ELEV and Sell After:
1 Month
3 Months
1 Year
Success Rate
2/7 ratings generated profit
Average Return
-37.64%
downgraded a sell rating 11 months ago
Copying Anupam Rama's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -37.64% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
ELEV Stock Forecast FAQ
What is ELEV’s average 12-month price target, according to analysts?
Currently, no data Available
What is ELEV’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ELEV, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ELEV a Buy, Sell or Hold?
Currently, no data Available
What is Elevation Oncology’s price target?
Currently, no data Available
What do analysts say about Elevation Oncology?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of ELEV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.